Study S001691

Prevention and Treatment Of Diabetes Complications With Gastric Surgery or Intensive Medicines

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT01974544
Acronym: PRODIGIES
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Masking: NONE
Status: UNKNOWN
Enrollment: 150
Start: 2013-05
Primary completion: 2015-12
Lead sponsor: Pontificia Universidad Catolica de Chile
Conditions: Type 2 Diabetes
Interventions: DRUG:Best medical treatment; PROCEDURE:gastric bypass; PROCEDURE:sleeve gastrectomy; DRUG:General interventions for all groups: blood presure; DRUG:General interventions for all groups: dysilipidemia; BEHAVIORAL:General interventions for all groups: lifestyle
Results posted: FALSE

Registered primary outcomes

Change in the microvascular complications of type 2 diabetes, specifically diabetic kidney disease [baseline at 1 month before the intervention and 3, 6, 9, 12, 15, 18, 21, 24, 27, 30, 33, 36 month after intervention]
Change in the microvascular complications of type 2 diabetes, specifically Retinopathy. [baseline at 1 month before the intervention, 12 y 24 month after intervention]
Change in the microvascular complications of type 2 diabetes, specifically peripheral and sympathic neuropathy. [baseline at 1 month before the intervention, 12, 24 y 36 month]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.